# Nanjing Polymer Medical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nanjing-polymer-medical-technology-co

- Industry: Medical Devices & Equipment
- Headquarters: Nanjing, China
- Website: www.njpolymer.cn
- Total disclosed funding: $29M
- Latest round: Series B (Apr 24, 2023)
- Investors on record: 8

## About

Based in Nanjing, China, and founded in 2016, Nanjing Polymer Medical Technology Co., Ltd. is a medical device developer, specializing in the development, production, and sale of sutures. The company obtained a type II suture registration certificate and production license in 2018 and a suture type III registration certificate in 2020. The company also established a factory phase II in 2021. In July 2025, it closed a series B+ funding.  The products provided by the company can be categorized into three categories which are absorbable surgical sutures barbed sutures, absorbable surgical sutures monofilament sutures, and non-absorbable surgical sutures barbed sutures. Products within include MDJ-2-0-33-02, KXS-2-0-75-02, ZF-2-77-01, etc. The products can be used in orthopedics, obstetrics, and gynecology, general surgery, urology, neurosurgery, thoracic surgery, anorectal surgery, etc.

## Funding rounds

- Series B, Apr 24, 2023, $29M — Nanjing Venture Capital, Huatai Zijin Investment, Alwin Capital, SDIC Unity Capital, Nanjing Southeast State-owned Assets Investment Group, Nanjing New Industry Investment, Rongzhen Investment, Jiangsu Mass Innovation Talent Joint Stock

## Investors

- Nanjing Venture Capital (https://capitalatlas.ai/funds/nanjing-venture-capital) — Series B
- Huatai Zijin Investment (https://capitalatlas.ai/funds/huatai-zijin-investment) — Series B
- Alwin Capital — Series B
- SDIC Unity Capital (https://capitalatlas.ai/funds/sdic-unity-capital) — Series B
- Nanjing Southeast State-owned Assets Investment Group — Series B
- Nanjing New Industry Investment (https://capitalatlas.ai/funds/nanjing-new-industry-investment) — Series B
- Rongzhen Investment — Series B
- Jiangsu Mass Innovation Talent Joint Stock — Series B